Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Jul 10, 2025 (15 months ago)

Bicillin L-A (Penicillin G Benzathine)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations; particulates identified during visual inspection

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02

Affected NDCs 60793-0701-02 60793-0701-10

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Bicillin L-A
penicillin G benzathine
NDC 60793-0701
1200000 [iU]/2mL Injection, Suspension
Intramuscular
Pfizer Laboratories Div Pfizer Inc Rx
Recalling firm
Pfizer Inc.
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0544-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Pfizer Inc.

All 2025 recalls

Other particulate / foreign matter recalls from 2025

All particulate / foreign matter recalls